Given that, our research team conducted several studies concerning the prognostic significance of semi-quantitative MGMT promoter methylation status obtained with both conventional MSP and Real-Time MSP assays among the Serbian population of glioblastoma/diffuse glioma patients [34,35,36]. The gene discussed is MGMT; the disease is glioblastoma.